What is NDC 70518-3143?

70518-3143 is the product NDC for metoprolol succinate, Metoprolol succinate 25 mg/1 tablet, extended release, listed with the FDA by REMEDYREPACK INC.. It has 2 package NDCs, shown above in 10- and 11-digit form.

REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for metoprolol succinate?

249 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

metoprolol succinate NDC 70518-3143

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-3143Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-3143Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-3143-0	7051831430070518314300	30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-3143-0)Marketed from Jul 5, 2021
70518-3143-1	7051831430170518314301	90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-3143-1)Marketed from Sep 24, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): metoprolol succinate
Generic name (nonproprietary): metoprolol succinate
Active ingredients: Metoprolol succinate — 25 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: REMEDYREPACK INC.NDC labeler code 70518
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203894
Marketing start: Jul 5, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 70518-3143_5267513e-c9e0-59ba-e063-6394a90a8424SPL ID 5267513e-c9e0-59ba-e063-6394a90a8424SPL set ID ea67ed64-47df-4728-8e62-c5d7316a71aaRxCUI 866427UNII TH25PD4CCB
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518314300 followed by a unit qualifier and the quantity

Package 70518-3143-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 22, 2026.

Indications (excerpt from the label)

Metoprolol succinate extended-release tablets, are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. (1.1) Angina Pectoris. (1.2) Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure (1.3) 1.1 Hypertension Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70518-3143

What is NDC 70518-3143?: 70518-3143 is the product NDC for metoprolol succinate, Metoprolol succinate 25 mg/1 tablet, extended release, listed with the FDA by REMEDYREPACK INC.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: metoprolol succinate.
What is the active ingredient?: Metoprolol succinate.
Who is the labeler?: REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for metoprolol succinate?: 249 other product NDCs are listed under this name. See all metoprolol succinate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other metoprolol succinate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Metoprolol Succinate	Metoprolol succinate 25 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-0883	67046-0883-03
Metoprolol Succinate	Metoprolol succinate 100 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1686	67046-1686-03
Metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1685	67046-1685-03
Metoprolol succinate	Metoprolol succinate 25 mg/1	Tablet, Extended releaseOral	Oryza pharmaceuticals Inc.	72516-025	72516-0025-0172516-0025-1072516-0025-50
Metoprolol Succinate	Metoprolol succinate 25 mg/1	Tablet, Extended releaseOral	BluePoint Laboratories	68001-684	68001-0684-0068001-0684-03
Metoprolol Succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	BluePoint Laboratories	68001-685	68001-0685-0068001-0685-03
Metoprolol Succinate	Metoprolol succinate 100 mg/1	Tablet, Extended releaseOral	BluePoint Laboratories	68001-686	68001-0686-0068001-0686-03
Metoprolol Succinate	Metoprolol succinate 200 mg/1	Tablet, Extended releaseOral	BluePoint Laboratories	68001-687	68001-0687-00
Metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1650	67046-1650-03
Metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Film coated, Extended releaseOral	Aphena Pharma Solutions - Tennessee, LLC	53401-009	53401-0009-3053401-0009-4553401-0009-53+3 more

All 250 metoprolol succinate NDCs

Other NDCs under ANDA 203894

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203894
Product	Strength	Form · route	Labeler	Product NDC
metoprolol succinate	Metoprolol succinate 100 mg/1	Tablet, Extended releaseOral	A-S Medication Solutions	50090-5411
metoprolol succinate	Metoprolol succinate 25 mg/1	Tablet, Extended releaseOral	A-S Medication Solutions	50090-5418
metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	St Mary's Medical Park Pharmacy	60760-634
metoprolol succinate	Metoprolol succinate 100 mg/1	Tablet, Extended releaseOral	St. Mary's Medical Park Pharmacy	60760-663
metoprolol succinate	Metoprolol succinate 200 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	63629-3286
metoprolol succinate	Metoprolol succinate 200 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	63629-9413
metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	Redpharm Drug	67296-1902
metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	NuCare Pharmaceuticals,Inc.	68071-2522
metoprolol succinate	Metoprolol succinate 100 mg/1	Tablet, Extended releaseOral	NuCare Pharmaceuticals,Inc.	68071-2651
metoprolol succinate	Metoprolol succinate 25 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-564
metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-565
metoprolol succinate	Metoprolol succinate 100 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-566
metoprolol succinate	Metoprolol succinate 200 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-567
metoprolol succinate	Metoprolol succinate 100 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-3122
metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-3164
metoprolol succinate	Metoprolol succinate 25 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	70771-1338
metoprolol succinate	Metoprolol succinate 50 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	70771-1339
metoprolol succinate	Metoprolol succinate 100 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	70771-1340
metoprolol succinate	Metoprolol succinate 200 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	70771-1341
metoprolol succinate	Metoprolol succinate 25 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	71335-1875

Showing 20 of 25.